PRIVATE AND CONFIDENTIALLetter Agreement • January 12th, 2026 • Grace Therapeutics, Inc. • Pharmaceutical preparations
Contract Type FiledJanuary 12th, 2026 Company Industry
ContractLetter Agreement • January 12th, 2026 • Grace Therapeutics, Inc. • Pharmaceutical preparations
Contract Type FiledJanuary 12th, 2026 Company Industry
PRIVATE AND CONFIDENTIALLetter Agreement • January 12th, 2026 • Grace Therapeutics, Inc. • Pharmaceutical preparations
Contract Type FiledJanuary 12th, 2026 Company IndustryThis letter serves to modify and amend the Letter Agreement (“Letter Agreement”) dated as of August 12, 2024, between you and Grace Therapeutics, Inc. (“Company”), as amended pursuant to that amendment dated November 12, 2025 (“Amendment No. 1”), containing the terms and conditions of your employment as Chief Executive Officer of the Company. This second amendment (“Amendment No. 2”) will be effective upon execution by you and the Company.
PRIVATE AND CONFIDENTIALLetter Agreement • January 12th, 2026 • Grace Therapeutics, Inc. • Pharmaceutical preparations
Contract Type FiledJanuary 12th, 2026 Company IndustryThis letter serves to modify and amend the Letter Agreement (“Letter Agreement”) dated as of November 12, 2025, between you and Grace Therapeutics, Inc. (“Company”) containing the terms and conditions of your employment as Vice President, Clinical Operations of the Company. This amendment (“Amendment No. 1”) will be effective upon execution by you and the Company.